-- 根據週三提交給香港交易所的文件顯示，SSY集團（HKG:2005）的全譜C反應蛋白和血清澱粉樣蛋白A/C反應蛋白檢測試劑盒已獲得中國河北省藥品管理局頒發的醫療器材註冊證書。 此試劑盒用於體外定量檢測人類血清、血漿或全血樣本中的C反應蛋白和血清澱粉樣蛋白A水平。
Related Articles
Mining & Metals
Earnings Flash (CFP.TO) Canfor Reports Q1 Revenue $1.36B, vs. $1.418M a Year Earlier
$CFP.TO
Research
BTIG Downgrades Embecta to Neutral From Buy
Embecta (EMBC) has an average rating of hold and mean price target of $8, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$EMBC
Mining & Metals
TELUS Digital Expands in Asia-Pacific and Argentina to Support Growing Demand for AI Data Services and Digital Customer Experience
TELUS' (T.TO, TU) global technology division, TELUS Digital, "significantly" expanded its global delivery footprint for AI-powered CX, AI data services, and trust and safety solutions over the last nine months, it said on Wednesday.This growth, the company said, "strengthens" TELUS Digital's presence across the Asia-Pacific region, including Indonesia, Thailand, Vietnam and Malaysia, and extends its reach in Latin America with a new location in Argentina.The company has also expanded two existing sites in Bengaluru and Ahmedabad, India, and added a new site in Kolkata, bringing its presence in the country to eight sites across six cities.U.S.-listed shares of TELUS were last seen down 0.3% at US$12.56 in pre-market trading.
$T.TO